Evidence map›Paper›PMID 37533697›Full record

ArticleBiomedical engineering and computational biology2023

Deep Learning Based Classification of Dermatological Disorders.

Lulwah AlSuwaidan

Abstract read
In one paragraph

Article in Biomedical engineering and computational biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. A novel Skin lesion prediction and classification technique: ViT-GradCAM.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024
    Article
  6. Review
  7. Leveraging deep neural networks to uncover unprecedented levels of precision in the diagnosis of hair and scalp disorders.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Lulwah AlSuwaidanInnovation and Emerging Technologies Center, Digital Government Authority, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Automated medical diagnosis has become crucial and significantly supports medical doctors. Thus, there is a demand for inventing deep learning (DL) and convolutional networks for analyzing medical images. Dermatology, in particular, is one of the domains that was recently targeted by AI specialists to introduce new DL algorithms or enhance convolutional neural network (CNN) architectures. A significantly high proportion of studies in the field are concerned with skin cancer, whereas other dermatological disorders are still limited. In this work, we examined the performance of 6 CNN architectures named VGG16, EfficientNet, InceptionV3, MobileNet, NasNet, and ResNet50 for the top 3 dermatological disorders that frequently appear in the Middle East. An Image filtering and denoising were imposed in this work to enhance image quality and increase architecture performance. Experimental results revealed that MobileNet achieved the highest performance and accuracy among the CNN architectures and can classify disorder with high performance (95.7% accuracy). Future scope will focus more on proposing a new methodology for deep-based classification. In addition, we will expand the dataset for more images that consider new disorders and variations.

Indexed as

classificationconvolutional neural networks (CNNs)Deep learningdermatological disordersimage classificationskin diseases

Identifiers

PMID37533697
PMCPMC10392223

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.